The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

The ASX200 started the week down around 0.7% at 7,955 points in early afternoon trade.

Australia’s second largest bank Westpac (ASX:WBC) has been down around 1.3% after appointing Anthony Miller as its new CEO. Starting in the role on the 16th of December, Mr Miller is currently CEO of the bank’s Business and Wealth division. He is well regarded internally and amongst external stakeholders, including major shareholders.

Westpac has been trading at $31.68.

All Australian sectors are in the red, weighed down by lower-than-expected Nonfarm Payroll jobs data in the United States.

Discretionary has been down 1.25%, followed closely by Financials 1.2%, and Energy and Telecommunications have both been down around 1%.

Control Bionics (ASX:CBL) has been up around 3.5% after inking a deal to distribute its NeuroNode device distributed throughout the UK and Ireland.

NeuroNode is a wearable device which transfers brain signals to enable speech and other functions. It treats conditions including Motor Neuron Disease and Cerebral Palsy.

Control Bionics has been exchanged at 9 cents.

Core Lithium (ASX:CXO) has been up point six of a percent after making a strategic investment in Charger Metals (ASX:CHR) and the Bynoe Project.

The deal represents around 10% of Charger and is a 30% free carried interest in Charger’s Bynoe Lithium Project from Lithium Australia (ASX:LIT).

Core Lithium has been traded at 8.4 cents.

More From The Market Online

Listen: HotCopper Wire Podcast #047 – Maybe just send an email next time, Albo

In this week’s HotCopper Wire episode, Isaac McIntyre and Jonathon Davidson break down (poke holes in) Albo’s national address from 7PM Wednesday, talk
The Market Online Video

Introducing Prairie Lithium: Saskatchewan’s permitted lithium project ready to scale

We've spoken to Prairie Lithium founder Zach Maurer about the explorer's overall mission, right after Macquarie's…
The Market Online Video

US growth, injectable iron pipeline: How AFT Pharma is driving toward $300 million by FY27

AFT Pharmaceuticals (ASX:AFP) is in a red-hot position as we head straight into FY26’s fourth quarter in Australia, and
The Market Online graphic with ASX-branded charts and the text "HotCopper Highlights" centred in white.

HotCopper Highlights, Week 15: Santos, Karoon, Viva all riding the Iran-fuelled Energy rollercoaster

Hello, hello, and welcome to HotCopper Highlights for Week 15, CY26, I’m Isaac McIntyre.